Tuberculosis (TB), caused by Mycobacterium tuberculosis, is currently on the rise as a result of reactivation of previously acquired mycobacterial disease in patients with HIV infection and AIDS. Patients infected with M. tuberculosis develop cellular immunity and delayed hypersensitivity to mycobacterial antigens. Delayed skin reactivity to purified protein derivative of tuberculin (PPD), particularly among people not immunized to mycobacterial antigens by vaccination with M. bovis BCG, serves as an important diagnostic tool in the United States. Unfortunately, reactivity to PPD is frequently lacking in patients with active TB even in the absence of HIV-related immunodeficiency. This lack of reactivity in an appreciable number of TB patients makes it important to identify other antigens which accurately and rapidly indicate active mycobacterial infection and which do not depend on integrity of host immune response. As part of our long-term interest in clarifying biochemical and immunologic roles of mycobacterial antigens in the pathogenesis of TB, we have identified antigens which may predict active disease. Mycobacterial proteins of the antigen 85 (Ag85) complex are major secretory proteins of M. tuberculosis. Our preliminary data suggest that these 30-32 kDa proteins can be readily detected in sera from some patients with active TB who are skin test negative. This in turn suggests that the presence of Ag85 proteins in the circulation may predict active mycobacterial infection. This hypothesis will be tested using an immunoassay based on mouse monoclonal anti-Ag85 recognizing species-specific and cross-reacting epitopes of M. tuberculosis Ag85 to measure levels of circulating Ag85 in HIV-infected and non-infected people with and without TB. Measured levels of Ag85 will be correlated with results of bacteriologic culture, PPD skin test reactivity and other clinical parameters.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI037014-01
Application #
2073593
Study Section
Special Emphasis Panel (SRC (85))
Project Start
1994-09-30
Project End
1997-07-31
Budget Start
1994-09-30
Budget End
1995-07-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
New York Medical College
Department
Pathology
Type
Schools of Medicine
DUNS #
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Zuniga, Jessica; Lillo, Luis; Shin, Junghee J et al. (2005) Salmonella enterica serovar Typhi O:1,9,12 polysaccharide-protein conjugate as a diagnostic tool for typhoid fever. J Clin Microbiol 43:4545-50
Sizemore, Robert C; Piva, Marta; Moore, LeeTerry et al. (2004) Modulation of delayed-type hypersensitivity responses in hairless guinea pigs by peptides derived from enkephalin. Neuroimmunomodulation 11:141-8
Kilbourn, A M; Godfrey, H P; Cook, R A et al. (2001) Serum antigen 85 levels in adjunct testing for active mycobacterial infections in orangutans. J Wildl Dis 37:65-71
Bentley-Hibbert, S I; Quan, X; Newman, T et al. (1999) Pathophysiology of antigen 85 in patients with active tuberculosis: antigen 85 circulates as complexes with fibronectin and immunoglobulin G. Infect Immun 67:581-8
Mangold, B J; Cook, R A; Cranfield, M R et al. (1999) Detection of elevated levels of circulating antigen 85 by dot immunobinding assay in captive wild animals with tuberculosis. J Zoo Wildl Med 30:477-83
Aron, L; Toth, C; Godfrey, H P et al. (1996) Identification and mapping of a chromosomal gene cluster of Borrelia burgdorferi containing genes expressed in vivo. FEMS Microbiol Lett 145:309-14